en

PRODUCT DETAIL

Lenalidomid Glenmark 5 mg

Code 9916C
MA number 59/0419/18-S
Product Form: cps dur 21x5 mg (blis.OPA/Al/PVC/Al)
MA Status: R - Valid Marketing Authorisation
Type of procedure: Decentralised
Therapeutic Class: 59 - IMMUNOPRAEPARATA
ATC:
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L04 Immunosuppressants
L04A Immunosuppressants
L04AX Other immunosuppressants
L04AX04 Lenalidomide
Shelf life: 36
Container: blister OPA/Al/PVC/Al
Route of admin.: Oral use
Prescription Status: Medicinal product subject to restricted medical prescription.
Legal basis: Article 10(1) generic application
MA issued: 19.12.2018
Validity: 19.12.2023
SPC: SPC_Lenalidomid Glenmark_ 5mg_10mg_15mg_25mg_05_2022.pdf  
PIL: PIL_Lenalidomid Glenmark_ 5mg_10mg_15mg_25mg_05_2022.pdf  
Safety feature Yes
Data update: 09.04.2019
eu-flag.png sk-flag.png